Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Mammal Labs LLC has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This single action is assigned to 1 distinct examiner within 1 distinct art unit. With only 1 pending office action, the company's prosecution activity is limited to a single technical matter. The presence of 1 distinct art unit indicates that the application falls under a specific biological or pharmaceutical classification at the patent office. Practitioners should note that the entire pending workload is concentrated in this one area.
HAUK TEODORO, PRICILA NMN is the busiest examiner for the portfolio, currently managing the 1 pending office action. Because this 1 distinct examiner handles the only pending matter, their specific approach to examination will determine the success of the application. Practitioners should focus on the examiner's previous rulings within the 1 distinct art unit. The company's immediate intellectual property goals are tied to the 1 pending office action currently under review. No other examiners or art units are currently involved in the company's pending portfolio in the Biotechnology & Pharmaceuticals sector.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HAUK TEODORO, PRICILA NMN | 1 | 50.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19085750 | IgY Antibody Compositions and Methods for Treating Avian Species | HAUK TEODORO, PRICILA NMN | — |
| Art Unit | Apps |
|---|---|
| 1645 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19085750 | IgY Antibody Compositions and Methods for Treating Avian Species | HAUK TEODORO, PRICILA NMN | 1645 | §101§102 | Non-Final OA | — | Pending | Mar 20, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMammal Labs LLC has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Pricila Nmn Hauk Teodoro has the most, with 1 of Mammal Labs LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
